The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Transforming lives, raising productivity
A new report from PwC for the Association of the British Pharmaceutical Industry reveals a picture of variable and slow access to the newest, innovative treatments.Read the report from PwC on the value of medicines
ABPI response to meeting between industry and Government on HRT supply
The ABPI welcomed today’s meeting between industry and Government on HRT supply.
ABPI welcomes appointment of Madelaine McTernan as Head of HRT Taskforce
It's important that women who need HRT can get the medicines they need
Novo Nordisk’s Pinder Sahota appointed President of the ABPI
Pinder will lead on overseeing the ABPI, the ABPI Board, and the ABPI’s Code of Practice, which is administered by the Prescription Medicines Code of Practice Authority (PMCPA).
ABPI response to guidance on the value of new antibiotics
The ABPI has welcomed the NICE's leadership in introducing a new approach to the evaluation of antibiotics.
Latest blogs and events
Worth the wait – The Goldacre review
Our thoughts on Professor Ben Goldacre’s “Better, broader, safer” report into health data.
Innovative medicines can bring hope to people with rare diseases – let’s get them to patients
England’s Action Plan for Rare Diseases contains important commitments to ensure that people with rare diseases get faster diagnosis, better care and timelier access to the treatments they desperately need.
By working together we can improve the lives of people with rare diseases
Many people are surprised to learn that rare diseases are actually comparatively common. A rare disease is defined as one that affects fewer than one in 2,000 people and it is reckoned that 300 million people worldwide have one. More than 6,000 rare diseases have been identified and about 72% of those have a genetic origin.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 June 2022
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Key content hubs
The COP26 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.
Coronavirus (COVID-19) was officially declared a pandemic by the World Health Organization on 12 March 2020. As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to this outbreak.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
Antibiotics are crucial for treating pneumonia. But they're under threat from drug resistance. With @asthmalunguk, we're raising awareness to ensure new antibiotics take flight. Find out more: https://t.co/RPyi6UAPv4 #TogetherForAntibiotics pic.twitter.com/KKomnw3BeE— ABPI (@ABPI_UK) May 27, 2022
For every 1 job in pharmaceutical manufacturing, 3 are supported elsewhere in Northern Ireland's economy. Find out more in our latest report by @Strath_FAI https://t.co/FNJqd5xLHu pic.twitter.com/Mc7SnV0k06— ABPI (@ABPI_UK) May 24, 2022
Antibiotics are one of the most powerful tools in healthcare. Without new antibiotics, drug resistance could affect the recovery of transplant patients after surgery. Find out more: https://t.co/RPyi6UAPv4 #TogetherForAntibiotics @Kidney_Research pic.twitter.com/Oxb1vSoxGQ— ABPI (@ABPI_UK) May 24, 2022
1⃣ For better #globalhealth security and disease surveillance, timely and unrestricted access to #pathogens and their genetic information is essential.#C19LessonsLearned #ShareDataOnPathogens— IFPMA (@IFPMA) May 24, 2022